S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Europe bans Russian diesel, other oil products over Ukraine
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Route to Super Bowl dangerous for Mexico's avocado haulers
Biden's State of the Union to tout policy wins on economy
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
How will EU ban and West's price cap on Russian diesel work?
Evacuations urged in Ohio town as train wreck smolders
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
'Knock at the Cabin' knocks off 'Avatar' at the box office
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Europe bans Russian diesel, other oil products over Ukraine
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Route to Super Bowl dangerous for Mexico's avocado haulers
Biden's State of the Union to tout policy wins on economy
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
How will EU ban and West's price cap on Russian diesel work?
Evacuations urged in Ohio town as train wreck smolders
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
'Knock at the Cabin' knocks off 'Avatar' at the box office
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Europe bans Russian diesel, other oil products over Ukraine
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Route to Super Bowl dangerous for Mexico's avocado haulers
Biden's State of the Union to tout policy wins on economy
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
How will EU ban and West's price cap on Russian diesel work?
Evacuations urged in Ohio town as train wreck smolders
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
'Knock at the Cabin' knocks off 'Avatar' at the box office
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Europe bans Russian diesel, other oil products over Ukraine
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Route to Super Bowl dangerous for Mexico's avocado haulers
Biden's State of the Union to tout policy wins on economy
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
How will EU ban and West's price cap on Russian diesel work?
Evacuations urged in Ohio town as train wreck smolders
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
'Knock at the Cabin' knocks off 'Avatar' at the box office
LON:AGL

ANGLE - AGL Share Forecast, Price & News

GBX 29.50
+1.00 (+3.51%)
(As of 02/3/2023 12:00 AM ET)
Add
Compare
Today's Range
29.50
▼
29.50
50-Day Range
24
▼
56
52-Week Range
22.20
▼
163.75
Volume
681,346 shs
Average Volume
5.54 million shs
Market Capitalization
£76.87 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
GBX 120
AGL stock logo

About ANGLE (LON:AGL) Stock

ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD multiplex analysis system for routine and focused multiplex analysis of DNA, RNA or protein biomarkers. The company was founded in 1994 and is based in Guildford, the United Kingdom.

Receive AGL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ANGLE and its competitors with MarketBeat's FREE daily newsletter.

AGL Stock News Headlines

January 13, 2023 | foxnews.com
WWE legend Kurt Angle credits daughter with saving him from drowning in scary jet ski incident
January 5, 2023 | proactiveinvestors.com
ANGLE says it sees significant expansion opportunities for the streamlined business as it moves into 2023
February 5, 2023 | Investor Place Media (Ad)
Cash Holders STILL Aren't Taking Steps to Prepare
Stocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.
January 5, 2023 | finance.yahoo.com
Angle plc Announces Appointment of Non-Executive Director
December 12, 2022 | finance.yahoo.com
Angle PLC Announces Two Parsortix Posters Presented at SABCS
November 2, 2022 | proactiveinvestors.com
ANGLE says Parsortix system used for multiple tests in breast cancer study
November 2, 2022 | finance.yahoo.com
Angle PLC Announces Multiple Downstream Analysis Techniques for CTCs
October 12, 2022 | proactiveinvestors.com
ANGLE inks first regional distribution deal for breakthrough liquid biopsy system
February 5, 2023 | Tradewins (Ad)
Know Your Profit Potential BEFORE You Trade!
I’m Chuck Hughes, ten-time trading champion and author of the coveted e-book, “Options Trading Made Easy”, the strategy guide that will teach you to calculate your trade’s profit potential before you risk any capital. Click here for a free copy now! pixel
October 12, 2022 | finance.yahoo.com
Angle PLC Announces First Regional Distribution Agreement
September 28, 2022 | msn.com
How to Manage Deadstick Approaches
September 28, 2022 | finance.yahoo.com
Angle PLC announces Study using Parsortix in head and neck cancer
September 12, 2022 | finanznachrichten.de
ANGLE plc: Angle PLC Announces Novel Assay; Predicts Malignancy in Pelvic Mass
September 12, 2022 | finance.yahoo.com
Angle PLC Announces Novel Assay; Predicts Malignancy in Pelvic Mass
September 2, 2022 | morningstar.com
Angle PLC Announces Notice of Interim Results and Webcast | Morningstar
August 13, 2022 | finance.yahoo.com
ANGLE plc (AGL.L)
June 29, 2022 | finance.yahoo.com
Angle PLC Announces Result of 2022 Annual General Meeting
June 27, 2022 | finanznachrichten.de
ANGLE plc: Angle PLC Announces Spread of Breast Cancer Accelerates During Sleep
June 22, 2022 | proactiveinvestors.com
ANGLE says second pharma services contract shows confidence in 'totally new approach'
June 22, 2022 | proactiveinvestors.com
ANGLE lands repeat business with pharma client - Proactive Investors USA
June 22, 2022 | finance.yahoo.com
Angle PLC Announces Secured Contract From Pharma Services Customer
June 17, 2022 | finanznachrichten.de
ANGLE plc: Angle PLC Announces Predicting Immunotherapy Response in SCLC
June 16, 2022 | proactiveinvestors.com
ANGLE: Researchers highlight potential of company's liquid biopsy in lung cancer
June 16, 2022 | apnews.com
Angle PLC Announces Predicting Immunotherapy Response in SCLC
June 15, 2022 | finance.yahoo.com
Angle PLC Announces Potential Role of Invasive Cellular Protrusions
June 14, 2022 | finanznachrichten.de
ANGLE plc: Angle PLC Announces Potential Role of Invasive Cellular Protrusions
May 30, 2022 | ca.proactiveinvestors.com
ANGLE inks prostate cancer study agreement with US healthcare group and its affiliate
See More Headlines
Receive AGL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ANGLE and its competitors with MarketBeat's FREE daily newsletter.

AGL Company Calendar

Last Earnings
1/30/2020
Today
2/05/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Medical Laboratories & Research
Sub-Industry
N/A
Sector
Medical
Current Symbol
LON:AGL
CUSIP
N/A
CIK
N/A
Web
www.angleplc.com
Phone
+44-1483-685830
Fax
N/A
Employees
102
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
GBX 120
High Stock Price Forecast
GBX 120
Low Stock Price Forecast
GBX 120
Forecasted Upside/Downside
+306.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
16.43
Current Ratio
6.55
Quick Ratio
6.18

Sales & Book Value

Annual Sales
£1.14 million
Price / Sales
67.67
Cash Flow
GBX 5.08 per share
Price / Cash Flow
5.80
Book Value
GBX 13.60 per share
Price / Book
2.17

Miscellaneous

Outstanding Shares
260,581,000
Free Float
N/A
Market Cap
£76.87 million
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. Andrew David William Newland (Age 61)
    Founder, CEO & Exec. Director
    Comp: $446k
  • Mr. Ian Francis Griffiths (Age 58)
    CFO, Fin. Director, Company Sec. & Exec. Director
    Comp: $284k
  • Mr. Martin Cooke (Age 54)
    Director of Operations & Regulatory Affairs
  • Mr. Andrew John Holder (Age 55)
    Head of Investor Relations
  • Mr. Paul Smith
    Chief Commercial Officer
  • Dr. Madeline Repollet
    Head of Clinical Laboratories
  • Ms. Anne-Sophie Pailhes-Jimenez
    Head of R&D - ANGLE Europe Ltd.
  • Mr. Michael O'Brien
    Bus. Devel. Director

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions













AGL Stock - Frequently Asked Questions

Should I buy or sell ANGLE stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for ANGLE in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" AGL shares.
View AGL analyst ratings or view top-rated stocks.

What is ANGLE's stock price forecast for 2023?

1 brokerages have issued twelve-month target prices for ANGLE's stock. Their AGL share price forecasts range from GBX 120 to GBX 120. On average, they predict the company's share price to reach GBX 120 in the next twelve months. This suggests a possible upside of 306.8% from the stock's current price.
View analysts price targets for AGL or view top-rated stocks among Wall Street analysts.

How have AGL shares performed in 2023?

ANGLE's stock was trading at GBX 50.50 at the beginning of the year. Since then, AGL stock has decreased by 41.6% and is now trading at GBX 29.50.
View the best growth stocks for 2023 here.

How were ANGLE's earnings last quarter?

ANGLE plc (LON:AGL) posted its quarterly earnings results on Thursday, January, 30th. The company reported ($3.33) earnings per share for the quarter.

What other stocks do shareholders of ANGLE own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ANGLE investors own include Yamana Gold (YRI), Asiamet Resources (ARS), Dekel Agri-Vision (DKL), Eldorado Gold (ELD), Polo Resources (POL), Silvercorp Metals (SVM), First Majestic Silver (AG), AFPO.L (AFPO), Ariana Resources (AAU) and Alamos Gold (AGI).

What is ANGLE's stock symbol?

ANGLE trades on the London Stock Exchange (LON) under the ticker symbol "AGL."

How do I buy shares of ANGLE?

Shares of AGL stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is ANGLE's stock price today?

One share of AGL stock can currently be purchased for approximately GBX 29.50.

How much money does ANGLE make?

ANGLE (LON:AGL) has a market capitalization of £76.87 million and generates £1.14 million in revenue each year.

How many employees does ANGLE have?

The company employs 102 workers across the globe.

How can I contact ANGLE?

ANGLE's mailing address is The Surrey Research Park 3 Frederick Sanger Road, GUILDFORD, GU2 7YD, United Kingdom. The official website for the company is www.angleplc.com. The company can be reached via phone at +44-1483-685830.

This page (LON:AGL) was last updated on 2/5/2023 by MarketBeat.com Staff